Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT

Creative Commons License

PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.4, ss.1223-1234, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 4
  • Basım Tarihi: 2022
  • Doi Numarası: 10.55730/1300-0144.5427
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1223-1234
  • Anahtar Kelimeler: Allergy, venom immunotherapy, Apis Mellifera, Vespula, double sensitization, omalizumab, IGE, ALLERGY, BEE, HONEYBEE, HYPERSENSITIVITY, EPIDEMIOLOGY, REACTIVITY, DIAGNOSIS, EFFICACY, VESPULA
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background/aim: Venom immunotherapy (VIT) is the most effective treatment method to prevent recurrent systemic reactions to Hymenoptera stings. In this study, the demographic characteristics of VIT patients, the success rates of VIT, the difficulties we encountered during VIT, and solutions for these difficulties in our clinic were presented.